BLV-CoCoMo-qPCR: a useful tool for evaluating bovine leukemia virus infection status

BMC Veterinary Research

Yoko Aida³  Tetsuo Nunoya²  Takashi Ohmori²  Tamako Matsuhashi⁴  Naohiko Kobayashi⁴  Junko Kohara⁵  Hironobu Murakami¹  Shin-nosuke Takeshima³  Mayuko Jimba³ 

[1] Japan Foundation for AIDS Prevention, Chiyoda-ku, Tokyo, 101-0061, Japan;Nippon Institute for Biological Science, 9-2221-1 Shinmachi Ome, Tokyo, 198-0024, Japan;Laboratory of Viral Infectious Diseases, Department of Medical Genome Sciences, Graduate School of Frontier Science, The University of Tokyo, Wako, Saitama 351-0198, Japan;Gifu Prefectural Livestock Research Institute, 4393–1 Makigahora, Kiyomi, Takayama, Gifu, 506-0101, Japan;Animal Research Center, Hokkaido Research Organization, Shintoku, Hokkaido, 080-0038, Japan

关键词: Experimental infection;    Serological test;    Proviral load;    Real-time PCR;    Bovine leukemia virus;   

Others  :  1119720
DOI  :  10.1186/1746-6148-8-167

 received in 2012-02-14, accepted in 2012-09-13,  发布年份 2012

【 摘 要 】

Background

Bovine leukemia virus (BLV) is associated with enzootic bovine leukosis, which is the most common neoplastic disease of cattle. BLV infects cattle worldwide, imposing a severe economic impact on the dairy cattle industry. Recently, we developed a new quantitative real-time polymerase chain reaction (PCR) method using Coordination of Common Motifs (CoCoMo) primers to measure the proviral load of known and novel BLV variants in BLV-infected animals. Indeed, the assay was highly effective in detecting BLV in cattle from a range of international locations. This assay enabled us to demonstrate that proviral load correlates not only with BLV infection capacity as assessed by syncytium formation, but also with BLV disease progression. In this study, we compared the sensitivity of our BLV-CoCoMo-qPCR method for detecting BLV proviruses with the sensitivities of two real-time PCR systems, and also determined the differences of proviral load with serotests.

Results

BLV-CoCoMo-qPCR was found to be highly sensitive when compared with the real-time PCR-based TaqMan MGB assay developed by Lew et al. and the commercial TaKaRa cycleave PCR system. The BLV copy number determined by BLV-CoCoMo-qPCR was only partially correlated with the positive rate for anti-BLV antibody as determined by the enzyme-linked immunosorbent assay, passive hemagglutination reaction, or agar gel immunodiffusion. This result indicates that, although serotests are widely used for the diagnosis of BLV infection, it is difficult to detect BLV infection with confidence by using serological tests alone. Two cattle were experimentally infected with BLV. The kinetics of the provirus did not precisely correlate with the change in anti-BLV antibody production. Moreover, both reactions were different in cattle that carried different bovine leukocyte antigen (BoLA)-DRB3 genotypes.

Conclusions

Our results suggest that the quantitative measurement of proviral load by BLV-CoCoMo-qPCR is useful tool for evaluating the progression of BLV-induced disease. BLV-CoCoMo-qPCR allows us to monitor the spread of BLV infection in different viewpoint compared with classical serotest.

【 授权许可】

   
2012 Jimba et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Hernandez FA, Miller RH, Schiebler GL: Rarity of coarctation of the aorta in the American Negro. J Pediatr 1969, 74(4):623-625.
• [2]Burny A, Bruck C, Cleuter Y, Couez D, Deschamps J, Ghysdael J, Gregoire D, Kettmann R, Mammerickx M, Marbaix G, et al.: Bovine leukemia virus, a versatile agent with various pathogenic effects in various animal species. Cancer Res 1985, 45(9 Suppl):4578s-4582s.
• [3]Aida Y, Miyasaka M, Okada K, Onuma M, Kogure S, Suzuki M, Minoprio P, Levy D, Ikawa Y: Further phenotypic characterization of target cells for bovine leukemia virus experimental infection in sheep. Am J Vet Res 1989, 50(11):1946-1951.
• [4]Konishi H, Kobayashi N, Hatanaka M: Defective human T-cell leukemia virus in adult T-cell leukemia patients. Mol Biol Med 1984, 2(4):273-283.
• [5]Korber B, Okayama A, Donnelly R, Tachibana N, Essex M: Polymerase chain reaction analysis of defective human T-cell leukemia virus type I proviral genomes in leukemic cells of patients with adult T-cell leukemia. J Virol 1991, 65(10):5471-5476.
• [6]Ohshima K, Kikuchi M, Masuda Y, Kobari S, Sumiyoshi Y, Eguchi F, Mohtai H, Yoshida T, Takeshita M, Kimura N: Defective provirus form of human T-cell leukemia virus type I in adult T-cell leukemia/lymphoma: clinicopathological features. Cancer Res 1991, 51(17):4639-4642.
• [7]Tsukasaki K, Tsushima H, Yamamura M, Hata T, Murata K, Maeda T, Atogami S, Sohda H, Momita S, Ideda S, et al.: Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease. Blood 1997, 89(3):948-956.
• [8]Tajima S, Ikawa Y, Aida Y: Complete bovine leukemia virus (BLV) provirus is conserved in BLV-infected cattle throughout the course of B-cell lymphosarcoma development. J Virol 1998, 72(9):7569-7576.
• [9]Burny A, Bex F, Bruck C, Cleuter Y, Dekegel D, Ghysdael J, Kettmann R, Leclercq M, Mammerickx M, Portetelle D: Biochemical and epidemiological studies on bovine leukemia virus (BLV). Haematol Blood Transfus 1979, 23:445-452.
• [10]Kettmann R, Deschamps J, Cleuter Y, Couez D, Burny A, Marbaix G: Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences. Proc Natl Acad Sci USA 1982, 79(8):2465-2469.
• [11]Elich TD, Lagarias JC: Formation of a photoreversible phycocyanobilin-apophytochrome adduct in vitro. J Biol Chem 1989, 264(22):12902-12908.
• [12]Powers MA, Radke K: Activation of bovine leukemia virus transcription in lymphocytes from infected sheep: rapid transition through early to late gene expression. J Virol 1992, 66(8):4769-4777.
• [13]Wang CT: Bovine leukemia virus infection in Taiwan: epidemiological study. J Vet Med Sci/ Japan Soc Vet Sci 1991, 53(3):395-398.
• [14]Monti GE, Frankena K: Survival analysis on aggregate data to assess time to sero-conversion after experimental infection with Bovine Leukemia virus. Prev Vet Med 2005, 68(2–4):241-262.
• [15]Kurdi A, Blankenstein P, Marquardt O, Ebner D: [Serologic and virologic investigations on the presence of BLV infection in a dairy herd in Syria]. Berl Munch Tierarztl Wochenschr 1999, 112(1):18-23.
• [16]Zaghawa A, Beier D: Abd El-Rahim IH, Karim I, El-ballal S, Conraths FJ, Marquardt O: An outbreak of enzootic bovine leukosis in upper Egypt: clinical, laboratory and molecular-epidemiological studies. J Vet Med B Infect Dis Vet Public Health 2002, 49(3):123-129.
• [17]Schoepf KC, Kapaga AM, Msami HM, Hyera JM: Serological evidence of the occurrence of enzootic bovine leukosis (EBL) virus infection in cattle in Tanzania. Trop Anim Health Prod 1997, 29(1):15-19.
• [18]Tajima S, Aida Y: The region between amino acids 245 and 265 of the bovine leukemia virus (BLV) tax protein restricts transactivation not only via the BLV enhancer but also via other retrovirus enhancers. J Virol 2000, 74(23):10939-10949.
• [19]Tajima S, Takahashi M, Takeshima SN, Konnai S, Yin SA, Watarai S, Tanaka Y, Onuma M, Okada K, Aida Y: A mutant form of the tax protein of bovine leukemia virus (BLV), with enhanced transactivation activity, increases expression and propagation of BLV in vitro but not in vivo. J Virol 2003, 77(3):1894-1903.
• [20]Lew AE, Bock RE, Molloy JB, Minchin CM, Robinson SJ, Steer P: Sensitive and specific detection of proviral bovine leukemia virus by 5' Taq nuclease PCR using a 3' minor groove binder fluorogenic probe. J Virol Methods 2004, 115(2):167-175.
• [21]Jimba M, Takeshima SN, Matoba K, Endoh D, Aida Y: BLV-CoCoMo-qPCR: quantitation of bovine leukemia virus proviral load using the CoCoMo algorithm. Retrovirology 2010, 7:91. BioMed Central Full Text
• [22]Kobayashi S, Tsutsui T, Yamamoto T, Hayama Y, Kameyama K, Konishi M, Murakami K: Risk factors associated with within-herd transmission of bovine leukemia virus on dairy farms in Japan. BMC Vet Res 2010, 6:1. BioMed Central Full Text
• [23]VanLeeuwen JA, Tiwari A, Plaizier JC, Whiting TL: Seroprevalences of antibodies against bovine leukemia virus, bovine viral diarrhea virus, Mycobacterium avium subspecies paratuberculosis, and Neospora caninum in beef and dairy cattle in Manitoba. Can Vet J La Rev Vet Can 2006, 47(8):783-786.
• [24]Inabe K, Ikuta K, Aida Y: Transmission and propagation in cell culture of virus produced by cells transfected with an infectious molecular clone of bovine leukemia virus. Virology 1998, 245(1):53-64.
• [25]Takeshima SN, Matsumoto Y, Miyasaka T, Arainga-Ramirez M, Saito H, Onuma M, Aida Y: A new method for typing bovine major histocompatibility complex class II DRB3 alleles by combining two established PCR sequence-based techniques. Tissue Antigens 2011, 78(3):208-213.
• [26]Xu A, van Eijk MJ, Park C, Lewin HA: Polymorphism in BoLA-DRB3 exon 2 correlates with resistance to persistent lymphocytosis caused by bovine leukemia virus. J Immunol 1993, 151(12):6977-6985.
• [27]Takeshima SN, Aida Y: Structure, function and disease susceptibility of the bovine major histocompatibility complex. Anim Sci J 2006, 77:13.
• [28]Untalan PM, Pruett JH, Steelman CD: Association of the bovine leukocyte antigen major histocompatibility complex class II DRB3*4401 allele with host resistance to the Lone Star tick, Amblyomma americanum. Vet Parasitol 2007, 145(1–2):190-195.
• [29]Takeshima S, Matsumoto Y, Chen J, Yoshida T, Mukoyama H, Aida Y: Evidence for cattle major histocompatibility complex (BoLA) class II DQA1 gene heterozygote advantage against clinical mastitis caused by Streptococci and Escherichia species. Tissue Antigens 2008, 72(6):525-531.
• [30]Schroth W, Goetz MP, Hamann U, Fasching PA, Schmidt M, Winter S, Fritz P, Simon W, Suman VJ, Ames MM, et al.: Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen. JAMA 2009, 302(13):1429-1436.
• [31]Florins A, Gillet N, Asquith B, Boxus M, Burteau C, Twizere JC, Urbain P, Vandermeers F, Debacq C, Sanchez-Alcaraz MT, et al.: Cell dynamics and immune response to BLV infection: a unifying model. Front Biosci J Virtual Libr 2007, 12:1520-1531.
• [32]Cockerell GL, Rovnak J: The correlation between the direct and indirect detection of bovine leukemia virus infection in cattle. Leuk Res 1988, 12(6):465-469.
• [33]Coulston J, Daniel RC, Lavin MF: Integration of bovine leukaemia virus at all stages of enzootic bovine leukosis. Arch Virol 1991, 119(1–2):13-23.
• [34]Eaves FW, Molloy JB, Dimmock CK, Eaves LE: A field evaluation of the polymerase chain reaction procedure for the detection of bovine leukaemia virus proviral DNA in cattle. Vet Microbiol 1994, 39(3–4):313-321.
• [35]Fechner H, Kurg A, Geue L, Blankenstein P, Mewes G, Ebner D, Beier D: Evaluation of polymerase chain reaction (PCR) application in diagnosis of bovine leukaemia virus (BLV) infection in naturally infected cattle. Zentralbl Vet Reihe B J Veterinary Med Ser B 1996, 43(10):621-630.
• [36]Jacobs RM, Song Z, Poon H, Heeney JL, Taylor JA, Jefferson B, Vernau W, Valli VE: Proviral detection and serology in bovine leukemia virus-exposed normal cattle and cattle with lymphoma. Can J Vet Res Rev Can Rech Vet 1992, 56(4):339-348.
• [37]Nagaoka Y, Kabeya H, Onuma M, Kasai N, Okada K, Aida Y: Ovine MHC class II DRB1 alleles associated with resistance or susceptibility to development of bovine leukemia virus-induced ovine lymphoma. Cancer Res 1999, 59(4):975-981.
• [38]Konnai S, Takeshima SN, Tajima S, Yin SA, Okada K, Onuma M, Aida Y: The influence of ovine MHC class II DRB1 alleles on immune response in bovine leukemia virus infection. Microbiol Immunol 2003, 47(3):223-232.
• [39]Aida Y, Okada K, Amanuma H: Phenotype and ontogeny of cells carrying a tumor-associated antigen that is expressed on bovine leukemia virus-induced lymphosarcoma. Cancer Res 1993, 53(2):429-437.